NASDAQ: BIOX
Bioceres Crop Solutions Corp Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their BIOX stock forecasts and price targets.

Forecast return on equity

Is BIOX forecast to generate an efficient return?

Company
56.94%
Industry
9.92%
Market
147.87%
BIOX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BIOX forecast to generate an efficient return on assets?

Company
6.84%
Industry
7.44%
BIOX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BIOX earnings per share forecast

What is BIOX's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$0.23
Avg 2 year Forecast
$0.57

BIOX revenue forecast

What is BIOX's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$431.7M+63.45%
Avg 2 year Forecast
$521.2M+97.33%
BIOX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BIOX revenue growth forecast

How is BIOX forecast to perform vs Agricultural Inputs companies and vs the US market?

Company
40.47%
Industry
3.33%
Market
16.51%
BIOX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BIOX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BIOX vs Agricultural Input Stocks

TickerPricePrice TargetUp/downsideConsensus
BIOX$0.34N/AN/A
SEED$1.02N/AN/A
NXTS$2.29N/AN/A
AVD$2.50N/AN/A
IPI$33.96$26.00-23.44%Strong Sell

Bioceres Crop Solutions Stock Forecast FAQ

What is BIOX's earnings growth forecast for 2027-2028?

(NASDAQ: BIOX) Bioceres Crop Solutions's forecast annual earnings growth rate of N/A is not forecast to beat the US Agricultural Inputs industry's average forecast earnings growth rate of 58.56%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 69.28%.

Bioceres Crop Solutions's earnings in 2026 is -$72,660,087.On average, 4 Wall Street analysts forecast BIOX's earnings for 2027 to be $14,920,560, with the lowest BIOX earnings forecast at $3,116,400, and the highest BIOX earnings forecast at $27,379,800.

In 2028, BIOX is forecast to generate $36,328,320 in earnings, with the lowest earnings forecast at $34,903,680 and the highest earnings forecast at $37,396,800.

If you're new to stock investing, here's how to buy Bioceres Crop Solutions stock.

What is BIOX's revenue growth forecast for 2027-2028?

(NASDAQ: BIOX) Bioceres Crop Solutions's forecast annual revenue growth rate of 40.47% is forecast to beat the US Agricultural Inputs industry's average forecast revenue growth rate of 3.33%, and it is also forecast to beat the US market's average forecast revenue growth rate of 16.51%.

Bioceres Crop Solutions's revenue in 2026 is $264,135,997.On average, 4 Wall Street analysts forecast BIOX's revenue for 2027 to be $27,457,392,000, with the lowest BIOX revenue forecast at $23,603,868,000, and the highest BIOX revenue forecast at $31,239,684,000.

In 2028, BIOX is forecast to generate $33,149,592,000 in revenue, with the lowest revenue forecast at $31,849,608,000 and the highest revenue forecast at $34,124,580,000.

What is BIOX's forecast return on assets (ROA) for 2027-2028?

(NASDAQ: BIOX) forecast ROA is 6.84%, which is lower than the forecast US Agricultural Inputs industry average of 7.44%.

What is BIOX's Earnings Per Share (EPS) forecast for 2027-2028?

(NASDAQ: BIOX) Bioceres Crop Solutions's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that BIOX's EPS will be $0.23 for 2027, with the lowest EPS forecast at $0.05, and the highest EPS forecast at $0.43. In 2028, BIOX's EPS is forecast to hit $0.57 (min: $0.55, max: $0.59).

What is BIOX's forecast return on equity (ROE) for 2027-2028?

(NASDAQ: BIOX) forecast ROE is 56.94%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.